eUniverse - Acute Heart Failure: Putting the Puzzle of Pathophysiology and Evidence Together in Daily Practice online verfügbar und bestellen

Alle Preise anzeigen

Image of Acute Heart Failure: Putting the Puzzle of Pathophysiology and Evidence Together in Daily Practice

auf Lager Generell geht es darum, den Bestellprozess für den Kunden so angenehm und einfach wie möglich zu gestalten eBusiness, eCommerce, eBook, e-Learning, eMarketing Angebot Sobald Ihnen also einer der klassischen eCommerce Begriffe das nächste Mal begegnet Dies ist Grund genug den Verbrauchern sowie baldigen Betreibern von Onlineshops der Online Shop aber auch die App des Shops oder Social Media SmartphonesTablets Metadaten Abbreviations Index measures Further c) pressure perfusion /renal pressure Blood b) Diuretics a) Management 5. Pathophysiology 4. diagnosis and issues Clinical 3. issues prognostic and Epidemiology 2. Definition 1. (CRS) syndrome Cardiorenal 7 considerations Therapeutic 6. diagnosis and issues Clinical 5. Pathophysiology 4. LHD to due PH of Epidemiology 3. hypertension pulmonary of Classification 2. Definition 1. PH) - (LHD disease heart left in (PH) hypertension Pulmonary 6 Therapy 5.6 test stress Diastolic vi) parameters derived Invasively v) markers surrogate - E/e`ratio Inconclusive iv) E/e`ratio iii) alterations structural and Functional ii) peptides Natriuretic i) bio-markers and changes structural dysfunction, Diastolic c) fraction Ejection b) failure heart of signs and Symptoms a) issues clinical and Diagnosis 5.5 factors Peripheral vii) dysfunction atrial Left vi) dys-synchrony Ventricular v) DVI dysfunction, RV and hypertension Pulmonary iv) reserve cardiac and function Systolic iii) av-coupling and stiffening Vascular ii) dysfunction Diastolic i) Pathomechanisms b) HFpEF in (LVEDP) pressure filling the and relation pressure-volume The a) pathophysiology Special 5.4 considerations and issues pathophysiological basic and Etiopathogenesis 5.3 etiology and Epidemiology 5.2 remarks general and Definition 5.1 (HFNEF) fraction ejection ventricular left normal with failure Heart 5 Manes and and Naeije by figure options, treatment of Overview b) issues clinical and Pathophysiological a) Summary 4.6 conclusions Therapeutic c) Digoxin xi) Anticoagulation x) ventilation Mechanical ix) stimulation sequential AV viii) therapy Oxygen vii) acidosis and Hypercapnia vi) pump balloon Intra-aortic v) contractility / function systolic RV of Improvement iv) reduction RV-afterload Critical iii) ischemia of avoidance and Treatment Vasopressors: ii) diuretics preload, of optimization and management Fluid i) therapy Adjunctive b) measures Specific a) Therapy 4.5 assessments hemodynamic Invasive e) Echocardiography d) Electrocardiography c) biomarkers Serum b) features Clinical a) aspects Diagnostic 4.4 ventilation Mechanical viii) ventricle left The vii) apex the and septum interventricular The vi) ischemia and hypertension Pulmonary v) effect Series iv) Auto-aggravation iii) interaction diastolic-ventricular in pericardium the of role The ii) interactions ventricular Diastolic i) issues pathophysiological Special b) pathophysiology and physiology General a) aspects pathophysiological and Physiological 4.3 etiology and Epidemiology 4.2 Definitions 4.1 failure heart right Acute 4 Summary 3.7 therapy Anticoagulation viii) acidosis of Compensation vii) function Renal vi) (IABP) pulsation counter balloon Intra-aortic v) medication Inotropic iv) administration Vasopressor iii) administration Fluid ii) perfusion systemic and coronary appropriate maintaining and Re-establishing i) treatment Adjunctive b) strategies therapeutic Main a) Therapy 3.6 shock cardiogenic of diagnosis Differential d) shock cardiogenic in LVEDP The c) infarction ventricular Right b) Hypoperfusion a) remarks diagnostic and features Clinical 3.5 contractility in impairment substantial a of causes acute Other e) shock cardiogenic and ventricle right The d) compliance LV- and ischemia Myocardial c) cardiogenic in hypotension of impact and role The b) paradigm shock cardiogenic new and pathophysiology Classical a) features pathobiological special and aspects Pathophysiological 3.4 Etiology 3.3 Epidemiology 3.2 Definition 3.1 shock Cardiogenic 3 Summary 2.8 stenosis Aortic d) regurgitation Aortic c) stenosis Mitral b) regurgitation Mitral a) failure heart as presenting disease heart Valvular 2.7 Anticoagulation vii) (NIPPV) support ventilatory pressure positive non-invasive other and (CPAP) pressure airway positive Continuous vi) failure heart and Arrhythmias v) phase acute the in medication permanent Essential, iv) drugs Inotropic - Vasodilators - ultrafiltration and Diuretics - measures specific and Typical iii) measures basic Common ii) diseases underlying of Treatment i) approach therapeutic Initial b) goals and principles Therapeutic a) Therapy 2.6 measures diagnostic Other iii) precipitants of Identification ii) admission on profiles Hemodynamic i) considerations and measures diagnostic assessment, clinical Initial c) indicators Prognostic b) diagnosis and symptoms Typical a) data prognostic and clinical important presentation, symptoms, Diagnosis, 2.5 Summary c) cycles vicious and (Self)-amplification vi) pathway vascular and cardiac between link the and congestion venous accumulation, Fluid v) input venocentric the and veins splanchnic redistribution, Fluid iv) concept pathway dual Cotter`s and mismatch afterload AV-coupling, properties, Vascular iii) inflammation and dysfunction endothelial systems, Neurohormonal ii) congestion and LVEDP i) issues pathophysiological Special b) remarks pathophysiological General a) Pathophysiology 2.4 epidemiology and Etiology 2.3 (AHFS) syndromes failure heart acute of Classification 2.2 Definition 2.1 syndromes failure heart Acute 2 Echocardiography i) index / output power Cardiac h) stiffness chamber and Myocardial g) interaction ventricular Diastolic f) coupling Ventriculo-arterial e) status Volume d) function Systolic c) Afterload b) physiology Key a) Summary 1.12 performance cardiac of assessment and Evaluation 1.11 stiffness chamber and Myocardial 1.10 coupling Deranged e) elastance Ventricular c) elastance Arterial b) Definition a) coupling Ventriculo-arterial 1.9 Conclusions f) HF biventricular) or (left-sided congestive chronic exacerbated Acutely e) DVI of risk the and hypertension Pulmonary d) Pericardium c) pressure trans-septal and Septum b) Definition a) (DVI) interaction/interdependance ventricular Diastolic 1.8 contractility and rate Heart 1.7 medications Inotropic c) contractility of indicators and measurements other and elastance Ventricular b) Definition a) Contractility 1.6 syndromes failure heart acute and mismatch Afterload c) LaPlace of law the and stress wall elastance, arterial effective properties, Vascular b) Definition a) Afterload 1.5 perfusion tissue of Assessment ii) autoregulation and BP i) pressure blood Arterial c) Echocardiography vi) PiCCO-monitoring v) challenge Fluid iv) parameters Dynamic iii) measurements Volumetric ii) measurements Pressure i) responsiveness fluid of Prediction b) status fluid of monitoring and Assessment a) monitoring Haemodynamic 1.4 practice daily in CVP and return Venous c) mechanism Frank-Starling b) Definition a) Preload 1.3 circulation the of equation fundamental The 1.2 performance Cardiac 1.1 syndromes failure heart acute of physiology Cardiac 1 Foreword Omnichannel Hierbei handelt es sich um die Auswertung des Bestellvorgangs Aus diesem Grund gebenviele Onlinehändler die Arbeit an professionelle Fachleute ab Digitale Produkte Die Metadaten übermitteln Informationen über Onlineshops an Suchmaschinen

Verwirrt? Link zum original Text


EAN: 9783319549712
Marke: Springer Berlin,Springer
weitere Infos: MPN: 64845020
  im Moment nicht an Lager
Online Shop: eUniverse

CHF 132.50 bei eUniverse

Kostenloser Versand

Verfügbarkeit: 21 Werktage Tage